Sagimet Biosciences Ownership | Who Owns Sagimet Biosciences?
Sagimet Biosciences Ownership Summary
Sagimet Biosciences is owned by 55.82% institutional investors, 14.65% insiders, and 29.52% retail investors.
SGMT Ownership Benchmark
Type | Name | % Inst | % Insiders | % Retail |
---|---|---|---|---|
Stock | Sagimet Biosciences | 55.82% | 14.65% | 29.52% |
Sector | Healthcare Stocks | 57.39% | 9.93% | 32.68% |
Industry | Biotech Stocks | 68.48% | 9.65% | 21.87% |
Institutional Ownership Trends
Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
---|---|---|---|---|---|---|---|---|---|---|
Dec 31, 2024 | 71 | 5.97% | 17,500,774 | -10.97% | 55 | 1.49% | 32 | 39.13% | 19 | -17.39% |
Sep 30, 2024 | 67 | -20.24% | 19,656,790 | -6.06% | 61 | 1.42% | 23 | -46.51% | 23 | 4.55% |
Jun 30, 2024 | 84 | 3.70% | 20,925,652 | -7.45% | 65 | 1.08% | 43 | -34.85% | 22 | 100.00% |
Mar 31, 2024 | 81 | 58.82% | 22,609,187 | 56.52% | 77 | 0.41% | 66 | 144.44% | 11 | 10.00% |
Dec 31, 2023 | 51 | 6.25% | 14,445,035 | -7.21% | 138 | 1.89% | 27 | -43.75% | 10 | - |
Recent Insider Transactions
Date | Name | Role | Activity | Value |
---|---|---|---|---|
Jul 23, 2024 | Kemble George | Executive Chairman | Sell | $74.83K |
Jul 19, 2024 | Martins Eduardo Bruno | Chief Medical Officer | Sell | $25.91K |
Jul 19, 2024 | Rozek Elizabeth | General Counsel and CCO | Sell | $33.83K |
Jul 19, 2024 | Kemble George | Executive Chairman | Sell | $43.60K |
Mar 26, 2024 | Happel David | President & CEO | Buy | $63.73K |
Insider Transactions Trends
Date | Buy | Sell |
---|---|---|
2025 Q1 | - | - |
2024 Q3 | - | 4 |
2024 Q2 | - | - |
2024 Q1 | 1 | - |
2023 Q3 | 1 | 1 |
SGMT Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools